share_log

Herbalife Analyst Ratings

Herbalife Analyst Ratings

康寶萊分析師評級
Benzinga ·  2023/08/03 08:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/03/2023 5.99% Mizuho $13 → $17 Maintains Neutral
06/07/2023 -18.95% Mizuho → $13 Initiates Coverage On → Neutral
03/01/2023 74.56% Citigroup $26 → $28 Maintains Buy
02/03/2023 -12.72% B of A Securities → $14 Initiates Coverage On → Underperform
11/01/2022 93.27% B. Riley Securities $38 → $31 Maintains Buy
11/01/2022 62.09% Citigroup $30 → $26 Maintains Buy
10/05/2022 87.03% Citigroup $36 → $30 Maintains Buy
07/12/2022 Jefferies Upgrades Hold → Buy
05/17/2022 Argus Research Downgrades Buy → Hold
05/04/2022 155.61% B. Riley Securities $50 → $41 Maintains Buy
05/04/2022 124.44% Citigroup $46 → $36 Maintains Buy
05/04/2022 62.09% Jefferies $60 → $26 Downgrades Buy → Hold
09/16/2021 224.19% Citigroup $57 → $52 Maintains Buy
06/29/2021 336.41% B. Riley Securities → $70 Initiates Coverage On → Buy
05/08/2020 249.13% Citigroup $49 → $56 Maintains Buy
02/20/2020 205.49% Citigroup $55 → $49 Maintains Buy
12/04/2019 242.89% Citigroup → $55 Assumes → Buy
08/02/2019 255.36% Citigroup $66 → $57 Maintains Buy
10/11/2018 305.24% Jefferies → $65 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
08/03/2023 5.99% 瑞穗 $13→$17 維護 中性
06/07/2023 -18.95% 瑞穗 →$13 開始承保 →中性
03/01/2023 74.56% 花旗集團 $26→$28 維護
02/03/2023 -12.72% B of A證券 →$14 開始承保 →表現不佳
11/01/2022 93.27% B.萊利證券 $38→$31 維護
11/01/2022 62.09% 花旗集團 $30→$26 維護
10/05/2022 87.03% 花旗集團 $36→$30 維護
07/12/2022 - 傑富瑞 升級 持有→購買
2022/05/17 - Argus研究 評級下調 購買→Hold
05/04/2022 155.61% B.萊利證券 $50→$41 維護
05/04/2022 124.44% 花旗集團 $46→$36 維護
05/04/2022 62.09% 傑富瑞 $60→$26 評級下調 購買→Hold
09/16/2021 224.19% 花旗集團 $57→$52 維護
2021/06/29 336.41% B.萊利證券 →$70 開始承保 →購買
05/08/2020 249.13% 花旗集團 $49→$56 維護
02/20/2020 205.49% 花旗集團 $55→$49 維護
2019/12/04 242.89% 花旗集團 →$55 假設 →購買
2019年08月02日 255.36% 花旗集團 $66→$57 維護
2018年10月11日 305.24% 傑富瑞 →$65 開始承保 →購買

What is the target price for Herbalife (HLF)?

康寶萊(Herbalife)的目標價是多少?

The latest price target for Herbalife (NYSE: HLF) was reported by Mizuho on August 3, 2023. The analyst firm set a price target for $17.00 expecting HLF to rise to within 12 months (a possible 5.99% upside). 7 analyst firms have reported ratings in the last year.

瑞穗於2023年8月3日報道了康寶萊(紐約證券交易所代碼:HLF)的最新目標價。這家分析公司將目標價定為17.00美元,預計HLF將在12個月內升至(可能上漲5.99%)。去年有7家分析公司公佈了評級。

What is the most recent analyst rating for Herbalife (HLF)?

康寶萊(Herbalife)最新的分析師評級是多少?

The latest analyst rating for Herbalife (NYSE: HLF) was provided by Mizuho, and Herbalife maintained their neutral rating.

對康寶萊(紐約證券交易所代碼:HLF)的最新分析師評級由瑞穗提供,康寶萊維持中性評級。

When is the next analyst rating going to be posted or updated for Herbalife (HLF)?

康寶萊(Herbalife)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Herbalife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Herbalife was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與康寶萊的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。康寶萊的上一次評級是在2023年8月3日提交的,因此你應該預計下一次評級將在2024年8月3日左右公佈。

Is the Analyst Rating Herbalife (HLF) correct?

分析師對康寶萊(Herbalife)的評級正確嗎?

While ratings are subjective and will change, the latest Herbalife (HLF) rating was a maintained with a price target of $13.00 to $17.00. The current price Herbalife (HLF) is trading at is $16.04, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的康寶萊(HLF)評級維持不變,目標價在13.00美元至17.00美元之間。康寶萊目前的股價為16.04美元,在分析師的預測範圍內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論